公开(公告)号：US20170231979A1

公开(公告)日：2017-08-17

申请号：US15586762

申请日：2017-05-04

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Robert A. STEINER ,  Charles CHAVKIN ,  Donald K. CLIFTON ,  Susan REED ,  Victor NAVARRO

IPC: A61K31/485 ,  A61K31/40 ,  A61K31/439 ,  A61K45/06

CPC classification number: A61K31/485 ,  A61K31/40 ,  A61K31/439 ,  A61K31/47 ,  A61K45/06

Abstract: The present disclosure is generally directed to compositions and methods for treating or limiting development of vasomotor symptoms in a subject.

公开(公告)号：US20210030745A9

公开(公告)日：2021-02-04

申请号：US16114661

申请日：2018-08-28

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Robert A. STEINER ,  Charles CHAVKIN ,  Donald K. CLIFTON ,  Susan REED ,  Victor NAVARRO

IPC: A61K31/485 ,  A61K31/47 ,  A61K31/40 ,  A61K45/06 ,  A61K31/439

Abstract: The present disclosure is generally directed to compositions and methods for treating or limiting development of vasomotor symptoms in a subject.

公开(公告)号：US20190255037A1

公开(公告)日：2019-08-22

申请号：US16114661

申请日：2018-08-28

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Robert A. STEINER ,  Charles CHAVKIN ,  Donald K. CLIFTON ,  Susan REED ,  Victor NAVARRO

IPC: A61K31/485 ,  A61K31/47 ,  A61K31/40 ,  A61K45/06 ,  A61K31/439

Abstract: The present disclosure is generally directed to compositions and methods for treating or limiting development of vasomotor symptoms in a subject.

公开(公告)号：US20240252484A1

公开(公告)日：2024-08-01

申请号：US18461812

申请日：2023-09-06

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Robert A. STEINER ,  Charles CHAVKIN ,  Donald K. CLIFTON ,  Susan REED ,  Victor NAVARRO

IPC: A61K31/485 ,  A61K31/40 ,  A61K31/439 ,  A61K31/47 ,  A61K45/06

CPC classification number: A61K31/485 ,  A61K31/40 ,  A61K31/439 ,  A61K31/47 ,  A61K45/06

Abstract: The present disclosure is generally directed to compositions and methods for treating or limiting development of vasomotor symptoms in a subject.

公开(公告)号：US20220125781A1

公开(公告)日：2022-04-28

申请号：US17365530

申请日：2021-07-01

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Robert A. STEINER ,  Charles CHAVKIN ,  Donald K. CLIFTON ,  Susan REED ,  Victor NAVARRO

IPC: A61K31/485 ,  A61K45/06 ,  A61K31/439 ,  A61K31/40 ,  A61K31/47

Abstract: The present disclosure is generally directed to compositions and methods for treating or limiting development of vasomotor symptoms in a subject.

公开(公告)号：US20170020855A1

公开(公告)日：2017-01-26

申请号：US15226408

申请日：2016-08-02

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Robert A. STEINER ,  Charles CHAVKIN ,  Donald K. CLIFTON ,  Susan REED ,  Victor NAVARRO

IPC: A61K31/47

CPC classification number: A61K31/485 ,  A61K31/40 ,  A61K31/439 ,  A61K31/47 ,  A61K45/06

Abstract: The present disclosure is generally directed to compositions and methods for treating or limiting development of vasomotor symptoms in a subject.

Abstract translation: 本公开一般涉及用于治疗或限制受试者中血管舒缩症状发展的组合物和方法。